Retraction Note: Predicting cancer prognosis and drug response from the tumor microbiome

Leandro C Hermida^#^{1

2}, E Michael Gertz^#¹, Eytan Ruppin³

Affiliations

¹ Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
² Department of Computer Science, University of Maryland, College Park, MD, USA.
³ Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA. eytan.ruppin@nih.gov.

^# Contributed equally.

Leandro C Hermida et al. Nat Commun. 2025.

. 2025 Sep 17;16(1):8308.

doi: 10.1038/s41467-025-64170-y.

Leandro C Hermida^#^{1

2}, E Michael Gertz^#¹, Eytan Ruppin³

¹ Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
² Department of Computer Science, University of Maryland, College Park, MD, USA.
³ Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA. eytan.ruppin@nih.gov.

^# Contributed equally.

No abstract available

Retraction of

Predicting cancer prognosis and drug response from the tumor microbiome.
Hermida LC, Gertz EM, Ruppin E. Hermida LC, et al. Nat Commun. 2022 May 24;13(1):2896. doi: 10.1038/s41467-022-30512-3. Nat Commun. 2022. Retraction in: Nat Commun. 2025 Sep 17;16(1):8308. doi: 10.1038/s41467-025-64170-y. PMID: 35610202 Free PMC article. Retracted.

1. Poore, G. D. et al. Retracted article: Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature579, 567–574 (2020). - PMC - PubMed